API Product

Fluticasone Propionate

fluticasone-propionate
Product Status:
Commercial
Available Grades:
  • Inhalation
  • Micronized
  • Non-Micronized
Regulatory Status:
JP DMF
US DMF
CEP
Production Sites:
  • Hovione Loures
Product Type:
  • Corticosteroids
CAS Number:
80474-14-2
Modes of Application:
  • Dermatological
  • Lung and Nasal administration
Common Indications:
  • Allergic rhinitis
  • Asthma
Last Inspection:
FDA May 2018

Hovione can customize Fluticasone propionate for inhalation with an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution reproducibility with a low span and amorphous content, providing highly stable API.

Hovione Fluticasone Propionate is available since 2001 and is approved in branded, generic and 505b2 applications.

With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API for inhalation, e.g. Salmeterol Xinafoate or Tiotropium Bromide.

 

 


This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.

Related files

Hovione Product Portfolio
pdf (84.51 KB)
Download